Approved weight loss drugs for obesity with a thorough emphasis on GLP-1 agonist medications: A systematic review
{{output}}
Background: Obesity is a worldwide health concern linked to cardiometabolic comorbidities such as type 2 diabetes, hypertension, dyslipidemia, and heart disease. The management of obesity using pharmacotherapy, especially with GL... ...
